CYP2E1 and ovarian carcinoma: Strikingly, analyses on acrylamide and endometrial and ovarian cancer risks in a prospective cohort study showed that non-smoking women who were homozygous for the wild type CYP2E1 alleles (of rs2480258, rs915906 and rs11101888) had higher risks of both endometrial and ovarian cancer than women with variant alleles for those three SNPs [15].